Notificação de entrada na fase nacional - PCT
#1.3
12/24/2024
RPI 2816
Application data
Number
112024019022Type
Filing
Publication
PCT
US2023064572 The application was filed at the INPI on 03/16/2023. It awaits formal examination and publication in the RPI gazette.
Latest action published by the INPI: 12/24/2024. We update with every new RPI gazette, published weekly.
Applicants
SPRINGWORKS THERAPEUTICS, INC.
US
Inventors
A. L. (pessoa física)
US
U. I. (pessoa física)
US
IPC Classification
Priority claims
US
63/321,036 · 03/17/2022
US
63/321,046 · 03/17/2022
Abstract
TRATAMENTO DE NEUROFIBROMAS CUTÂNEOS COM MIRDAMETINIB. A presente invenção refere-se a métodos para tratar neurofibromas cutâneos (cNF) compreendendo administrar a um paciente em necessidade do mesmo mirdametinib ou um sal farmaceuticamente aceitável do mesmo.
Publications in the Brazilian Industrial Property Gazette (RPI).
#1.3
12/24/2024
RPI 2816
#1.1
09/24/2024
RPI 2803
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.